 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Brenner S. on NEWS: Paper Alert: Do Blood-Borne Factors Control Brain Aging?, Eotaxin or CCL 11 is known to recruit eosinophiles. This is thought to indicate a relationship... 24 Sep 2011.
|
 |
 |
 |
 |
 |
Brenner S. on PAPER: Xiao F. et al., 2011, This is potentially a good Alzheimer's model.
There may be a number of different toxins or... 9 Jun 2011.
|
 |
 |
 |
 |
 |
Brenner S. on LIVE DISCUSSION: Focus on the Locus! (Ceruleus, That Is, in Alzheimer’s Disease), I think the locus ceruleus is definitely implicated in Alzheimer’s disease, perhaps in some way... 7 Dec 2010.
|
 |
 |
 |
 |
 |
Brenner S. on NEWS: San Diego: ALS Research Goes to the Dogs, The dog models do probably have a lot of advantages over mice, especially since they seem to be... 7 Dec 2010.
|
 |
 |
 |
 |
 |
Brenner S. on PAPER: Assis-Nascimento P. et al., 2007, This probably is a very important paper with reference to the progression of Alzheimer disease,... 10 Apr 2007.
|
 |
 |
 |
 |
 |
Brenner S. on NEWS: Presenilins Open Escape Hatch for ER Calcium, I was quite interested in the regulation of calcium within the endoplasmic reticulum, and... 19 Sep 2006.
|
 |
 |
 |
 |
 |
Brenner S. on NEWS: Memantine Wins FDA Approval, I am optimistic about the introduction of memantine, and think it is more likely to affect a (if... 19 Nov 2003.
|
 |
 |
 |
 |
 |
Brenner S. on NEWS: Donepezil to Broaden Its Reach?, It seems Donepezil is relatively safe and can help people with additional problems other than... 23 Sep 2003.
|
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |